|
|
Previous Article | Table of Contents | Next Article 
Ex vivo expansion with stem cell factor and interleukin-11 augments both
short-term recovery posttransplant and the ability to serially transplant
marrow
TL Holyoake, MG Freshney, L McNair, AN Parker, PJ McKay, WP Steward, E Fitzsimons, GJ Graham and IB Pragnell
Cancer Research Campaign Beatson Laboratories, Beaston Institute for Cancer
Research, Glasgow, Scotland.
The characterization of many cytokines involved in the control of
hematopoiesis has led to intense investigation into their potential use in
ex vivo culture to expand progenitor numbers. We have established the
optimum ex vivo culture conditions that allow substantial amplification of
transient engrafting murine stem cells and which, simultaneously, augment
the ability to sustain serial bone marrow transplantation (BMT). Short-term
incubation of unfractionated BM cells in liquid culture with stem cell
factor (SCF) and interleukin-11 (IL- 11) produced a 50-fold amplification
of clonogenic multipotential progenitors (CFU-A). Following such ex vivo
expansion, substantially fewer cells were required to rescue lethally
irradiated mice. When transplanted in cell doses above threshold for
engraftment, BM cells expanded ex vivo resulted in significantly more rapid
hematopoietic recovery. In a serial transplantation model, unmanipulated BM
was only able to consistently sustain secondary BMT recipients, but BM
expanded ex vivo has sustained quaternary BMT recipients that remain alive
and well more than 140 days after 4th degree BMT. These results show
augmentation of both short-term recovery posttransplant and the ability to
serially transplant marrow by preincubation in culture with SCF and IL-11.
Volume 87,
Issue 11,
pp. 4589-4595,
06/01/1996
Copyright © 1996 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Seita, M. Asakawa, J. Ooehara, S.-i. Takayanagi, Y. Morita, N. Watanabe, K. Fujita, M. Kudo, J. Mizuguchi, H. Ema, et al.
Interleukin-27 directly induces differentiation in hematopoietic stem cells
Blood,
February 15, 2008;
111(4):
1903 - 1912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Bonig, G. V. Priestley, and T. Papayannopoulou
Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines
Blood,
January 1, 2006;
107(1):
79 - 86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sakai, T. Kajiume, H. Inoue, R. Kanno, M. Miyazaki, Y. Ninomiya, and M. Kanno
TCDD Treatment Eliminates the Long-Term Reconstitution Activity of Hematopoietic Stem Cells
Toxicol. Sci.,
March 1, 2003;
72(1):
84 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Audet, C. L. Miller, S. Rose-John, J. M. Piret, and C. J. Eaves
Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells
PNAS,
February 13, 2001;
98(4):
1757 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bryder and S. E. W. Jacobsen
Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro
Blood,
September 1, 2000;
96(5):
1748 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Zandstra, D. A. Lauffenburger, and C. J. Eaves
A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis
Blood,
August 15, 2000;
96(4):
1215 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. J. Oostendorp, J. Audet, and C. J. Eaves
High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo
Blood,
February 1, 2000;
95(3):
855 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Weich, M. Fitzgerald, A. Wang, J. Calvetti, J. Yetz-Aldape, S. Neben, and K. J. Turner
Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro
Blood,
January 15, 2000;
95(2):
503 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Takagi, T. Nakamura, T. Sawada, A. Kaneko, M. Nozaki-Ukai, T. Nakahata, T. Yokota, and T. Heike
Chimeric Cytokine Receptor Can Transduce Expansion Signals in Interleukin 6 Receptor alpha (IL-6Ralpha )-, IL-11Ralpha -, and gp130-low to -negative Primitive Hematopoietic Progenitors
Mol. Biol. Cell,
November 1, 1999;
10(11):
3633 - 3642.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Guenechea, J.C. Segovia, B. Albella, M. Lamana, M. Ramirez, C. Regidor, M.N. Fernandez, and J.A. Bueren
Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo-Expanded Human CD34+ Cord Blood Cells
Blood,
February 1, 1999;
93(3):
1097 - 1105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shimizu, M. Ogawa, M. Kobayashi, G. Almeida-Porada, and E. D. Zanjani
Engraftment of Cultured Human Hematopoietic Cells in Sheep
Blood,
May 15, 1998;
91(10):
3688 - 3692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood,
February 15, 1998;
91(4):
1101 - 1134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Breems, E. A.W. Blokland, K. E. Siebel, A. E.M. Mayen, L. J.A. Engels, and R. E. Ploemacher
Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells
Blood,
January 1, 1998;
91(1):
111 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Miller and C. J. Eaves
Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability
PNAS,
December 9, 1997;
94(25):
13648 - 13653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Nandurkar, L. Robb, D. Tarlinton, L. Barnett, F. Kontgen, and C. G. Begley
Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis
Blood,
September 15, 1997;
90(6):
2148 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Albella, J. C. Segovia, and J. A. Bueren
Does the Granulocyte-Macrophage Colony-Forming Unit Content in Ex Vivo-Expanded Grafts Predict the Recovery of the Recipient Leukocytes?
Blood,
July 1, 1997;
90(1):
464 - 470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Moore, H. Ema, and I. R. Lemischka
In Vitro Maintenance of Highly Purified, Transplantable Hematopoietic Stem Cells
Blood,
June 15, 1997;
89(12):
4337 - 4347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Du and D. A. Williams
Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use
Blood,
June 1, 1997;
89(11):
3897 - 3908.
[Full Text]
[PDF]
|
 |
|
|
|